Dydrogesterone
- Generic Name
- Dydrogesterone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H28O2
- CAS Number
- 152-62-5
- Unique Ingredient Identifier
- 90I02KLE8K
- Background
A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation.
- Indication
Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.
- Associated Conditions
- Infertility, Menstrual Distress (Dysmenorrhea), Premenstrual Syndrome (PMS), Recurrent Miscarriages, Spontaneous Abortions
- Associated Therapies
- Assisted Reproductive Technology therapy, Menstrual Regulation
Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 406
- Registration Number
- NCT02128685
- Locations
- 🇭🇰
Department of Obstetrics and Gynaecology, PYNEH, Chai Wan, Hong Kong
🇭🇰Department of Obstetrics & Gynaecology, Queen Mary Hospital, Hong Kong, Hong Kong
🇭🇰Department of Obstetrics & Gynaecology, Kwong Wah Hospital, Mong Kok, Hong Kong
The Effect of Different Types of Progestin on Sleeping of Menopausal Women
- Conditions
- Interventions
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Chiang Mai University
- Target Recruit Count
- 100
- Registration Number
- NCT02086032
- Locations
- 🇹🇭
Obstetrics and Gynecology department, Faculty of Medicine, Chiang Mai University, Muang, Chiang Mai, Thailand
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2011-08-26
- Lead Sponsor
- Abbott Products
- Target Recruit Count
- 71
- Registration Number
- NCT00193674
- Locations
- 🇵🇱
Site Reference ID/Investigator# 61183, Poznan, Poland
🇵🇱Site Reference ID/Investigator# 61184, Szczecin, Poland
🇦🇹Site Reference ID/Investigator# 61182, Vienna, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.